|5.53||+0.03 / +0.55%|
As of 4:00pm ET
|5.53||0.00 / 0.00%|
The 5 analysts offering 12-month price forecasts for Merrimack Pharmaceuticals Inc have a median target of 15.00, with a high estimate of 16.00 and a low estimate of 13.00. The median estimate represents a +171.25% increase from the last price of 5.53.
The current consensus among 6 polled investment analysts is to Buy stock in Merrimack Pharmaceuticals Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.